**EXCLUSIVE - KILKER v GLAXOSMITHKLINE COURT DOCUMENTS

"Now, this particular type of drug we talked about during jury selection a little bit. It is called the selective serotonin reuptake inhibitor. That is actually a name that GlaxoSmithKline coined. They coined that phrase. You are going to learn they coined it because Paxil is the most selective, the most powerful of the serotonin reuptake inhibitors."


The documents are located on the Baum, Hedlund, Aristei & Goldman web page.


In the Court of Common Pleas, First Judicial District of Pennsylvania, Civil Trial Division

LYAM KILKER, a Minor, by MICHELLE M. DAVID, as Next Friend and Individually
VS.
SMITHKLINE BEECHAM CORPORATION d/b/a GLAXOSMITHKLINE



9/15/09 AM: Opening Statements




Plaintiff’s Expert: David Healy, MD FRCPsych, Neuropyschopharmacologist, Professor of Psychiatry, Cardiff University,University Hospital Wales North Wales Department of Psychological Medicine

9/15/09 PM: David Healy, M.D. -- Direct Examination




9/16/09 AM: David Healy, M.D. -- Direct (continued)




9/16/09 PM: David Healy, M.D. -- Direct (continued); Cross Examination






9/17/09 AM: David Healy, M.D. -- Cross (continued); Redirect





9/17/09 PM: David Healy, M.D. -- Recross; Redirect






Plaintiffs Expert: Suzanne Parisian, M.D., former FDA employee


9/18/09 AM: Suzanne Parisian, M.D. -- Direct Examination




9/18/09 PM: Suzanne Parisian, M.D. -- Direct (continued)




Plaintiff’s Expert: Shira Kramer, Ph.D., Epidemiologist

9/21/09 AM: Shira Kramer, Ph.D. -- Direct Examination



9/21/09 PM: Shira Kramer, Ph.D. -- Direct (continued); Cross Examination; Redirect




Plaintiff’s Expert: Ra-id Abdulla, M.D.


9/23/09 AM: Ra-id Abdulla, M.D. -- Direct Examination





9/23/09 PM: Ra-id Abdulla, M.D. -- Cross Examination; Redirect



Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING